Search clinical trials for: CC-11050
Total 900 results
-
CelgeneActive, not recruitingMultiple MyelomaFrance, United States, Canada, Spain, Italy
-
Sir Mortimer B. Davis - Jewish General HospitalCompleted
-
Kadmon Corporation, LLCCompletedIdiopathic Pulmonary FibrosisUnited States
-
Celgene CorporationCompletedCrohn's DiseaseFrance, United States, United Kingdom, Israel
-
CelgeneNot yet recruitingHealthy ParticipantsUnited States
-
Weill Medical College of Cornell UniversityRecruiting
-
Institut Cancerologie de l'OuestCompletedProstate Cancer RecurrentFrance
-
CelgeneCompletedLeukemia Lymphocytic Chronic B-CellUnited States, Austria
-
Yale UniversityCelgene CorporationCompletedMultiple MyelomaUnited States
-
Celgene CorporationPrologue Research InternationalCompletedNon-Small Cell Lung CancerUnited States
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsNot yet recruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
Jonsson Comprehensive Cancer CenterNot yet recruitingProstate Carcinoma | Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8United States
-
Medical University of South CarolinaCelgene CorporationCompletedLarge B-Cell Diffuse LymphomaUnited States
-
CelgeneCompletedMyelodysplastic SyndromeSpain, United Kingdom, Denmark, Germany, France, Greece, Italy, Sweden, Belgium, United States, Luxembourg, Norway
-
Weill Medical College of Cornell UniversityTerminated
-
M.D. Anderson Cancer CenterCompleted
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, Germany
-
CelgeneCompleted
-
CelgeneICON Clinical ResearchCompletedMelanoma | Neoplasm MetastasisAustralia, United Kingdom, Ukraine, Germany, Estonia, Latvia, Lithuania, Netherlands, South Africa
-
Chang Gung Memorial HospitalCompletedLatent Cancer ProstateTaiwan
-
Jason Robert GotlibCelgene CorporationTerminatedLeukemia | Anemia | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)United States
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedKidney CancerUnited States
-
Washington University School of MedicineCompleted
-
The Christie NHS Foundation TrustCelgene Corporation; Leukemia Research FundTerminatedChronic Lymphocytic LeukaemiaUnited Kingdom
-
Celgene CorporationCompletedSafety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)Prostate CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterWithdrawn
-
CelgeneActive, not recruitingLeukemia, Myeloid, AcuteUnited States, Australia, Brazil, Canada, Czechia, Finland, France, Germany, Italy, Korea, Republic of, Mexico, Portugal, Russian Federation, Spain, United Kingdom, Belgium, Taiwan, Austria, Ireland, Israel, Lithuania, Poland, Turkey
-
Stanford UniversityCelgene CorporationWithdrawnPulmonary FibrosisUnited States
-
University of California, DavisCelgeneCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
University of Santiago de CompostelaMinisterio de Economía y Competitividad, Spain; Ministry of Work and Welfare...Completed
-
Mayo ClinicNational Cancer Institute (NCI)CompletedChronic Myeloproliferative Disorders | Secondary MyelofibrosisUnited States
-
CelgeneTerminatedSoft Tissue SarcomaUnited States
-
CelgeneCompletedMultiple MyelomaCanada, Denmark, Australia, Belgium, France, Germany, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom, Czechia, Greece
-
CelgenePrologue Research InternationalCompleted
-
The Lymphoma Academic Research OrganisationCelgene CorporationCompletedRelapsed/Refractory B-cell LymphomaFrance
-
Celgene CorporationCompletedMyelodysplastic SyndromesUnited States, Denmark, Australia, Belgium, Czech Republic, France, Germany, Greece, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedPain | Advanced CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
Southern Europe New Drug OrganizationCelgene CorporationUnknown
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationRecruitingAML, Adult | Relapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITDFrance
-
CelgeneCompletedNeoplasmsUnited States, France, Italy, Poland, Spain, United Kingdom
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Spain
-
University of MichiganCompletedProstate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
CelgeneTerminatedLeukemia, MyeloidUnited States, France, Belgium, Spain
-
CelgeneCompleted
-
CelgeneCompletedMyelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterCelgeneCompletedLeukemia | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLLUnited States